George S Corpuz, Xue Dong, Sophia Salingaros, Carlos Urrea de la Puerta, Nicholas A Vernice, Gillian M O'Connell, Hector F Salazar, Jini Jeon, David M Bednarski, Eric Eisenhut, Tony Eisenhut, Lawrence J Bonassar, Jason A Spector
{"title":"Decellularization of Cartilage Xenograft with Supercritical CO<sub>2</sub>.","authors":"George S Corpuz, Xue Dong, Sophia Salingaros, Carlos Urrea de la Puerta, Nicholas A Vernice, Gillian M O'Connell, Hector F Salazar, Jini Jeon, David M Bednarski, Eric Eisenhut, Tony Eisenhut, Lawrence J Bonassar, Jason A Spector","doi":"10.1177/19373384261477631","DOIUrl":null,"url":null,"abstract":"<p><p>Decellularized cartilage xenograft is an emerging alternative to autograft or allograft techniques, though its application has been limited by the toxicity that conventional chemical decellularizing agents have on tissue structure and the environment. We describe a nontoxic, scalable, and environmentally sustainable ovine cartilage decellularization protocol utilizing supercritical CO<sub>2</sub>(scCO<sub>2</sub>). Five scCO<sub>2</sub> decellularization protocols were evaluated in various ovine cartilage dimensions, of which the multicycle scCO<sub>2</sub> method was selected for <i>in vivo</i> evaluation of ovine zested cartilage, ovine minced cartilage, and human minced cartilage. Cartilage groups were enclosed in porous polylactic acid (PLA) scaffolds and implanted subcutaneously on rat dorsa along with an empty scaffold control group. Rats were euthanized after 1, 3, and 6 months for volumetric, histological, and biomechanical analysis of implants. The efficiencies of scCO<sub>2</sub> decellularization was enhanced by multicycle process or additional reagents, as well as the smaller dimensions of processed cartilage, as confirmed by DNA quantification and nucleic staining. Preserved structural integrity was evidenced by intact cartilage structure, lacunae components, and collagenous content postprocessing on histology. Implantation in a murine model for 6 months demonstrated excellent neo-tissue ingrowth with minimal inflammatory response. Biomechanical testing revealed no significant differences in moduli or hydraulic permeability of minced and zested samples, before and after the decellularization treatment. The resulting stiffness after implantation mimicked the physical properties of other cartilaginous tissues. In conclusion, we demonstrate the effective decellularization of ovine cartilage graft with a scCO<sub>2</sub> protocol while maintaining native tissue architecture and biomechanical properties with a minimal immunogenic response <i>in vivo</i>. Further development of this approach promises to augment surgeon choice of materials used for cartilage reconstruction.</p>","PeriodicalId":23154,"journal":{"name":"Tissue engineering. Part C, Methods","volume":" ","pages":"297-309"},"PeriodicalIF":2.0000,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tissue engineering. Part C, Methods","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/19373384261477631","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/8/12 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"CELL & TISSUE ENGINEERING","Score":null,"Total":0}
引用次数: 0
Abstract
Decellularized cartilage xenograft is an emerging alternative to autograft or allograft techniques, though its application has been limited by the toxicity that conventional chemical decellularizing agents have on tissue structure and the environment. We describe a nontoxic, scalable, and environmentally sustainable ovine cartilage decellularization protocol utilizing supercritical CO2(scCO2). Five scCO2 decellularization protocols were evaluated in various ovine cartilage dimensions, of which the multicycle scCO2 method was selected for in vivo evaluation of ovine zested cartilage, ovine minced cartilage, and human minced cartilage. Cartilage groups were enclosed in porous polylactic acid (PLA) scaffolds and implanted subcutaneously on rat dorsa along with an empty scaffold control group. Rats were euthanized after 1, 3, and 6 months for volumetric, histological, and biomechanical analysis of implants. The efficiencies of scCO2 decellularization was enhanced by multicycle process or additional reagents, as well as the smaller dimensions of processed cartilage, as confirmed by DNA quantification and nucleic staining. Preserved structural integrity was evidenced by intact cartilage structure, lacunae components, and collagenous content postprocessing on histology. Implantation in a murine model for 6 months demonstrated excellent neo-tissue ingrowth with minimal inflammatory response. Biomechanical testing revealed no significant differences in moduli or hydraulic permeability of minced and zested samples, before and after the decellularization treatment. The resulting stiffness after implantation mimicked the physical properties of other cartilaginous tissues. In conclusion, we demonstrate the effective decellularization of ovine cartilage graft with a scCO2 protocol while maintaining native tissue architecture and biomechanical properties with a minimal immunogenic response in vivo. Further development of this approach promises to augment surgeon choice of materials used for cartilage reconstruction.
期刊介绍:
Tissue Engineering is the preeminent, biomedical journal advancing the field with cutting-edge research and applications that repair or regenerate portions or whole tissues. This multidisciplinary journal brings together the principles of engineering and life sciences in the creation of artificial tissues and regenerative medicine. Tissue Engineering is divided into three parts, providing a central forum for groundbreaking scientific research and developments of clinical applications from leading experts in the field that will enable the functional replacement of tissues.
Tissue Engineering Methods (Part C) presents innovative tools and assays in scaffold development, stem cells and biologically active molecules to advance the field and to support clinical translation. Part C publishes monthly.